Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 148 of 2999 -
Thursday, March 12 2026 | 03:21:53 AM

Homeland Completes Phase II Drilling at Coyote Basin Confirming Extensive Near-Surface Radioactivity

Vancouver, British Columbia–(Newsfile Corp. – February 10, 2026) – Homeland Uranium Corp. (TSXV: HLU) (OTCQB: HLUCF) (FSE: D3U) (“Homeland” or the “Company“) reports the completion of its Phase II exploration drilling program at the 100%-owned Coyote Basin Uranium Project (the “Project“) (see Figure 1). The Company completed 33 drillholes totaling …

Read More »

Frost & Sullivan Published the 2025 Blue Book on the Industry Development Status and Future Trends of Medical Aesthetic Injection Products

Shanghai, China–(Newsfile Corp. – February 10, 2026) – Frost & Sullivan has conducted comprehensive research on the medical aesthetic injection products industry and published the “2025 Blue Book on the Industry Development Status and Future Trends of Medical Aesthetic Injection Products”. The blue book aims to provide a comprehensive analysis …

Read More »

Provenance Gold Appoints Vice President of Exploration

Vancouver, British Columbia–(Newsfile Corp. – February 10, 2026) – Provenance Gold Corp. (CSE: PAU) (OTCQB: PVGDF) (“Provenance” or the “Company”) is pleased to announce the appointment of Luke Schranz as Vice President of Exploration, effective immediately.  Mr. Schranz will be responsible for the day-to-day operations, planning and overseeing all aspects …

Read More »

TempraMed Partners with Super-Pharm, Israel’s Leading Pharmacy Chain to Commence a National Product Roll Out Strategy

Super-Pharm operates nationwide, serving millions of consumers annually Vancouver, British Columbia–(Newsfile Corp. – February 10, 2026) – TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (“TempraMed” or the “Company“), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is excited to announce the rollout of its products across Super-Pharm, …

Read More »

Inverite Attends CLA’s Automotive Finance Canada 2026 as Industry Focus Intensifies on Fraud, Digital Approvals, and Stronger Risk Signals

Vancouver, British Columbia–(Newsfile Corp. – February 10, 2026) – Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRF) (FSE: 2V0) (“Inverite”), a Canadian risk infrastructure company providing real-time financial data and decisioning signals, specializing in real-time bank verification, income and affordability analytics, and AI-driven risk-modeling and fraud-prevention solutions, will attend the Canadian Lenders …

Read More »

Syntholene Energy Selects Dynelectro, Developer of “World’s Most Efficient Electrolyzer” as Vendor for Synthetic Fuel Demonstration Facility

Relationship Represents Potential Long Term Scalability of High Efficiency Supply Chain from Demonstration to Commercial Scale Chicago, Illinois–(Newsfile Corp. – February 10, 2026) – SYNTHOLENE ENERGY CORP (TSXV: ESAF) (FSE: 3DD0) (OTCQB: SYNTF) (“Syntholene” or the “Company”) announces that it has selected Dynelectro ApS (Denmark) as the electrolyzer technology vendor …

Read More »

Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board

Montreal, Quebec–(Newsfile Corp. – February 10, 2026) – Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (“Defence” or the “Company”), a publicly traded biotechnology and precision intracellular drug-delivery company, reported on its Scientific Advisory Board (“SAB”) meeting held on January 30, 2026, focused on advancing the strategic positioning of Accum® …

Read More »